Abstract

Our results suggest that bFGF in urine deserves further evaluation of its potential use as a monitor of therapy or as a predictor of outcome once a cancer has been diagnosed.

Keywords

Basic fibroblast growth factorMedicineBladder cancerInternal medicineCancerUrinePercentileMetastasisUrinary systemGastroenterologyOncologyUrologyGrowth factor

MeSH Terms

Analysis of VarianceFemaleFibroblast Growth Factor 2HumansImmunoenzyme TechniquesMaleMiddle AgedNeoplasmsNeovascularizationPathologicPredictive Value of TestsPrognosisProportional Hazards ModelsSurvival Analysis

Affiliated Institutions

Related Publications

Publication Info

Year
1994
Type
article
Volume
86
Issue
5
Pages
356-361
Citations
473
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

473
OpenAlex
3
Influential
362
CrossRef

Cite This

Mai Nguyen, Hiroyuki Watanabe, Andrew E. Budson et al. (1994). Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of Cancers. JNCI Journal of the National Cancer Institute , 86 (5) , 356-361. https://doi.org/10.1093/jnci/86.5.356

Identifiers

DOI
10.1093/jnci/86.5.356
PMID
7508518

Data Quality

Data completeness: 81%